Sign In
Buy FBCG
$63.39
-0.670 (-1.05%)
At Close: Jun 03, 2026
FBCG: An Attractive ETF For Dip Buyers
12:58am, Monday, 28'th Apr 2025
Fidelity Blue Chip Growth ETF offers a prime buying opportunity due to its fundamental analysis and bottom-up stock picking approach, focusing on high-growth sectors. The current market selloff has cr
Active ETFs Steal the Show: Topping $1 Trillion Mark
08:33am, Wednesday, 02'nd Apr 2025
Despite the ETF industry's passive roots, active has stolen the show. Active ETF assets just topped the $1 trillion threshold, making up nearly 10% of the total ETF pie.
3 Fidelity ETFs to Buy in March to Generate Big Passive Income In Retirement
02:36pm, Wednesday, 05'th Mar 2025
Retail investors do not need to worry about picking individual stocks to ensure steady returns.
Fidelity's Blue Chip Growth ETF Makes Sense in All Market Environments
01:18pm, Friday, 28'th Feb 2025
Many investors favor blue chip stocks for their stability. This stability makes a blue chip ETF a familiar option during periods of market and economic stress.
Undercovered ETFs: Growth, Income, TIPS, Poland +
08:00am, Thursday, 20'th Feb 2025
The 'Undercovered' Dozen series highlights 12 lesser-known ETFs offering potential investment opportunities for investors. Kurtis Hemmerling shares a bearish take on iShares Russell Top 200 Growth ETF
5 Actively Managed ETFs That Outperformed Warren Buffett Last Year
07:36am, Thursday, 13'th Feb 2025
Warren Buffett has outperformed the S&P 500 for many years, and he continues to deliver impressive gains for investors.
FBCG: Strong Historical Returns But High Volatility And Fees
03:18am, Tuesday, 28'th Jan 2025
FBCG offers investors exposure to blue chip U.S. large cap growth equities. The fund's gross expense ratio of 0.60% is significantly higher than comparable index ETFs and somewhat higher than comparab
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
06:10pm, Monday, 13'th Jan 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil
VIDEO: ETF of the Week: FBCG
01:02pm, Monday, 13'th Jan 2025
On this episode of “ETF of the Week” podcast, VettaFi's Head of Research Todd Rosenbluth joined Chuck Jaffe of Money Life to talk about the Fidelity Blue Chip Growth ETF (FBCG). Chuck Jaffe: One
ETF of the Week: Fidelity Blue Chip Growth ETF (FBCG)
05:22pm, Thursday, 09'th Jan 2025
VettaFi's Head of Research Todd Rosenbluth discussed the Fidelity Blue Chip Growth ETF (FBCG) on this week's “ETF of the Week” podcast with Chuck Jaffe of “Money Life.” For more news, informa
Equity Dominates ETF Inflows at the Start of 2025
12:05pm, Tuesday, 07'th Jan 2025
Investors poured in 31.7 billion in capital to start 2025, with U.S. equity ETFs leading the way.
Blue-Chip ETF (FBCG) Hits New 52-Week High
10:16am, Tuesday, 07'th Jan 2025
For investors seeking momentum, Fidelity Blue Chip Growth ETF FBCG is probably on the radar. The fund just hit a 52-week high and has moved up 46.4% from its 52-week low of $32.91 per share.
3 Top-Performing Fidelity ETFs Offer 2024 Insight
01:31pm, Friday, 03'rd Jan 2025
With the end of the year on the horizon, investors often reflect on insights from the market's performance. Three ETFs from Fidelity Investments can offer some notable takeaways as they are likely to
Under the Hood of Fidelity's Blue Chip Growth ETF
11:35am, Thursday, 21'st Nov 2024
Fidelity Investments' blue chip growth ETF has generated attractive returns for investors. The Fidelity Blue Chip Growth ETF (FBCG) is a U.S. equity growth strategy with a large-cap bias.
Under Radar Active Equity ETFs
03:46pm, Wednesday, 23'rd Oct 2024
Actively managed equity ETFs have continued to gain traction in 2024 and risen in value. Some of the top performing funds were focused on in vogue, large-cap growth stocks such as the American Century
